13F-HR filed by Defilade Capital Management, L.P.
Defilade Capital Management, L.P. filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 39 holding rows worth $746,947,371.
- Accession
- 0002088557-26-000008
- Filer
- CIK 2088557
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 39 entries on the cover page, a total value of $746,947,371 stated on the cover page (in dollars after the unit check, H1), rows summing to $746,947,371 with VALUE read as dollars as filed, 13F file number 028-26338. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 532457108 | COM | 39,086 | $46,880,921 | dollars as filed | |
| Pfizer Inc. | 717081103 | COM | 1,771,743 | $42,663,571 | dollars as filed | |
| VEEVA SYS INC CL A COM | 922475108 | Stock | 236,709 | $42,008,746 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 682,005 | $39,024,326 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 433,699 | $35,376,827 | dollars as filed | |
| BAXTER INTL INC | 071813109 | COM | 1,459,380 | $31,113,982 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 281,838 | $30,049,568 | dollars as filed | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 317,426 | $27,327,204 | dollars as filed | |
| INSULET CORP COM | 45784P101 | Stock | 176,932 | $26,937,897 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 51,934 | $26,037,630 | dollars as filed | |
| Abbott Laboratories | 002824100 | COM | 285,778 | $25,931,496 | dollars as filed | |
| ASCENDIS PHARMA A/S | K08588103 | ORD SHS *A* | 94,843 | $25,296,525 | dollars as filed | |
| SOLVENTUM CORP COM SHS | 83444M101 | Stock | 316,454 | $24,414,426 | dollars as filed | |
| Medtronic Plc | G5960L103 | COM | 303,301 | $23,727,237 | dollars as filed | |
| ELANCO ANIMAL HEALTH INC COM | 28414H103 | Stock | 864,080 | $21,265,009 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 546,848 | $20,293,529 | dollars as filed | |
| ENVISTA HOLDINGS CORPORATION | 29415F104 | COM | 726,108 | $19,132,946 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 82,827 | $15,511,841 | dollars as filed | |
| ICU MED INC | 44930G107 | COM | 105,700 | $15,495,620 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 393,441 | $15,226,167 | dollars as filed | |
| LANTHEUS HLDGS INC | 516544103 | COM | 132,662 | $14,717,522 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 1,490,286 | $14,634,609 | dollars as filed | |
| ELEDON PHARMACEUTICALS INC | 28617k101 | COM | 3,525,338 | $13,889,832 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 376,870 | $12,037,228 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 924,758 | $11,568,723 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,047,690 | $11,346,483 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 3,670,135 | $11,193,912 | dollars as filed | |
| GLOBUS MED INC CL A | 379577208 | Stock | 139,637 | $11,032,719 | dollars as filed | |
| ENOVIS CORPORATION | 194014502 | COM | 531,945 | $11,011,262 | dollars as filed | |
| EVOMMUNE INC | 30054Y107 | COMMON STOCK | 793,145 | $10,540,897 | dollars as filed | |
| TELEFLEX INCORPORATED | 879369106 | COM | 80,118 | $10,155,758 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 391,866 | $10,078,794 | dollars as filed | |
| GLAUKOS CORP COM | 377322102 | Stock | 66,519 | $9,296,695 | dollars as filed | |
| STAAR SURGICAL CO COM PAR $0.01 | 852312305 | Stock | 322,126 | $9,241,795 | dollars as filed | |
| PACS GROUP INC | 69380Q107 | COM SHS | 215,675 | $9,196,382 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 239,440 | $8,959,845 | dollars as filed | |
| LIVANOVA PLC | G5509L101 | SHS | 107,373 | $8,829,282 | dollars as filed | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 1,674,999 | $3,098,748 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 7,558,756 | $2,401,417 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0002088557-26-000008 | this filing | 2026-08-14 | acceptance time not in the bulk data set |